HIV TestingNCT07317687
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
An observational study of HIV Testing and HEPATITIS C (HCV), run by West Virginia University at 1 site in United States.
Trial summary
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- HIV Testing, HEPATITIS C (HCV), Syphilis
- What is being tested?
- Rapid Fingerstick Test and Blood Draw for lab test
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Jan 2026to Jan 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Participants will include patients in Berkeley and Jefferson Counties of West Virginia who visit the WVU Medicine Street Medicine Clinic.
Who may be able to join
- Patients of the WVU Medicine Street Medicine team
Who cannot join
- Patients under the age of 18
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
WVU Department of Family Medicine - Eastern Division
Harpers Ferry, West Virginia, 25425
Dana Bechtold, DO, 304-535-4108, dana.bechtold@hsc.wvu.edu
Dana Bechtold, DO
About this study
Official title: Rapid HIV, Hepatitis C, and Syphilis Screening in a Rural Street Medicine Clinic in West Virginia
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.
- Conditions
- HIV Testing, HEPATITIS C (HCV), Syphilis, Hepatitis B Virus (HBV)
- Being tested
- Rapid Fingerstick Test, Blood Draw for lab test
- Keywords
- Street Medicine, Rapid Fingerstick Testing
- Medical subject headings
- Hepatitis C, Syphilis, Hepatitis B
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rapid Fingerstick TestDiagnostic test
Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes
Blood Draw for lab testDiagnostic test
Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results
| Study group | Role | What they receive |
|---|---|---|
| Participants receiving fingerstick test | * Will get a quick fingerstick test for HIV, Hepatitis C, and syphilis.
* Will receive results in 10-20 minutes.
* If positive, will be offered immediate care and/or a referral.
* If positive, blood draw will be offered on site to confirm results or referred to a WVU Medicine clinic location for follow-up blood test.
* Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes). Receives: Diagnostic Test: Rapid Fingerstick Test | |
| Participants receiving blood-draw test | Participants receiving blood-draw test:
* Will get a blood draw to test for HIV, Hepatitis B \& C, and syphilis
* Will receive results in approximately 3 days (via MyChart message and phone call, or in person at site)
* If positive, will be offered immediate care and/or a referral for follow-up care. • Will be invited to answer questions about the feelings and experiences with screening (about 15 minutes). Receives: Diagnostic Test: Blood Draw for lab test | |
| Participants who decline screening | Participants who decline screening: • Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of Finger Stick
Percentage of participants that opted to take the rapid finger stick test.
Measured: Day 1
Percentage of Blood Draw
Percentage of participants that opted to take the blood draw test.
Measured: Day 1
Percentage that decline screening
Percentage of participants that opted to decline screening
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2026
- Study start21 Jan 2026
- Primary completionJan 2028 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIV TestingStudies of the same condition, open and under way.
- More trials run by West Virginia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- West Virginia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dana Bechtold, West Virginia University
- Investigators
- Dana Bechtold, DO, Principal investigator, West Virginia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07317687
- Sponsor's protocol ID
- 2507193944
- Status last verified
- Jul 2026
- First submitted
- 19 Dec 2025
- Last updated
- 13 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rapid HIV, Hepatitis C, and Syphilis Screening in a Rural Street Medicine Clinic in West Virginia
- ClinicalTrials.gov ID
- NCT07317687
- Acronym / sponsor ID
- 2507193944
- Conditions
- HIV Testing, HEPATITIS C (HCV), Syphilis, Hepatitis B Virus (HBV)
- Keywords
- Street Medicine, Rapid Fingerstick Testing
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- West Virginia UniversityUniversity, hospital or other
- Study start
- 21 Jan 2026 (actual)
- Primary completion
- Jan 2028 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 5 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Participants receiving fingerstick test | – | Diagnostic Test: Rapid Fingerstick Test* Will get a quick fingerstick test for HIV, Hepatitis C, and syphilis. * Will receive results in 10-20 minutes. * If positive, will be offered immediate care and/or a referral. * If positive, blood draw will be offered on site to confirm results or referred to a WVU Medicine clinic location for follow-up blood test. * Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes). |
| Participants receiving blood-draw test | – | Diagnostic Test: Blood Draw for lab testParticipants receiving blood-draw test: * Will get a blood draw to test for HIV, Hepatitis B \& C, and syphilis * Will receive results in approximately 3 days (via MyChart message and phone call, or in person at site) * If positive, will be offered immediate care and/or a referral for follow-up care. • Will be invited to answer questions about the feelings and experiences with screening (about 15 minutes). |
| Participants who decline screening | – | –Participants who decline screening: • Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Participants will include patients in Berkeley and Jefferson Counties of West Virginia who visit the WVU Medicine Street Medicine Clinic.
Key inclusion criteria (1 listed)
- Patients of the WVU Medicine Street Medicine team
Key exclusion criteria (1 listed)
- Patients under the age of 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rapid Fingerstick TestFingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes | Diagnostic test | Participants receiving fingerstick test |
| Blood Draw for lab testBlood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results | Diagnostic test | Participants receiving blood-draw test |
Primary outcome
Percentage of Finger Stick
Time frame: Day 1
Percentage of participants that opted to take the rapid finger stick test.
Percentage of Blood Draw
Time frame: Day 1
Percentage of participants that opted to take the blood draw test.
Percentage that decline screening
Time frame: Day 1
Percentage of participants that opted to decline screening
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for HIV Testing
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Recruiting
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test
HIV1 Infection, HIV 2 Infection
Enrolling by invitation
Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
HIV, HIV - Human Immunodeficiency Virus
Active, not recruiting
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
HIV Infections, STI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dana Bechtold, DO principal investigator
West Virginia University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of HIV Testing and HEPATITIS C (HCV), run by West Virginia University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dana Bechtold, DO (304-535-6343, dana.bechtold@hsc.wvu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of Finger Stick (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.